This trial will compare two different ways of using transcranial magnetic stimulation to treat people with major depressive disorder. The goal is to see if one method is better than the other at treating both depression and anxiety.
2 Primary Ā· 6 Secondary Ā· Reporting Duration: Baseline (before treatment), 3 weeks (after 15 treatments), and 6 weeks (after 30 treatments)
Experimental Treatment
40 Total Participants Ā· 2 Treatment Groups
Primary Treatment: Transcranial magnetic stimulation Ā· No Placebo Group Ā· Phase 2
Age 18 - 65 Ā· All Participants Ā· 4 Total Inclusion Criteria
Mark āYesā if the following statements are true for you:| Massachusetts | 100.0% |
| 65+ | 50.0% |
| 18 - 65 | 50.0% |
| Brigham & Women's Hospital | 100.0% |
| Did not meet criteria | 50.0% |
| Met criteria | 50.0% |